Aida Habtezion
Aida Habtezion
Aida Habtezion IS AN ASSOCIATE PROFESSOR OF MEDICINE (GASTROENTEROLOGY AND HEPATOLOGY) AT Stanford University [1]
Academic History
Aida Habtezio is a researcher who focus her research on Gastroenterology, Inflammatory Bowel Diseases (IBD), Ulcerative Colitis, Crohn's Disease and Microscopic colitis (Collagenous & Lymphocytic colitis).
Education
Residency: University of Western Ontario (1999) Canada
Board Certification, Internal Medicine: American Board of Internal Medicine &, Royal College of Physicians of Canada (1999)
Fellowship: University of Toronto (2002) Canada
Medical Education: McMaster University Michael G DeGroote School of Medicine Registrar (1996) Canada
Fellowship: Stanford University Pain Management Fellowship (2005) CA
Academic Appointments
Associate Professor, Medicine - Gastroenterology & Hepatology
Member, Stanford University Bio-X Initiative
Member, Maternal & Child Health Research Institute (MCHRI)
Member, Stanford Cancer Institute
Faculty Fellow, Stanford ChEM-H
Honors & Awards
Clinical Scientist Career Development Award (K08), NIH/NIDDK (2006-2011)
Inducted to The American Society for Clinical Investigation, ASCI (2017)
Endowed Ballinger-Swindells Family Scholar, Stanford University (2016 - Present)
Immunology Faculty Mentor of the Year, Stanford University (2015 - 2016)
Harold Amos Medical Faculty Development Award, Robert Wood Johnson Foundation (2011-2015)
DDC Named Investigator, Stanford Digestive Disease Center (DDC) (2010-2011)
Administrative Appointments
Member, Stanford Diabetes Research Center (2018 - Present)
Member, AGA Institute Research Awards Panel Committee (2018 - 2020)
Associate Professor of Medicine, Division of Gastroenterology & Hepatology, Stanford University (2017 - Present)
Member, Stanford Immunology PhD Program Committee (2017 - 2020)
Editorial Board, Digestive Diseases and Sciences (2008 - 2013)
Instructor, Division of Gastroenterology & Hepatology, Stanford University (2007 - 2010)
Publications
Aida Habtezion had published numerous articles such as:
Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients.
PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
Clinical and immunomodulatory effects of transcutaneous vagal nerve stimulation for idiopathic gastroparesis
Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis.
Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.